June 20th 2025
Some of the companies that received American samples, FDA said, are partially owned or controlled by the Communist Party in China.
EMA Recommends Seven Medicines for Approval in October
October 13th 2023The recommended medicines include treatments for Duchenne muscular dystrophy, relapsed or refractory multiple myeloma, hyperargininemia, invasive candidiasis, menopause symptoms, and diagnostic medicines for characterizing lesions.